Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000146244 | SCV000193488 | benign | not specified | 2018-01-02 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000146244 | SCV000338620 | likely benign | not specified | 2016-02-03 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000364030 | SCV001017329 | benign | Kabuki syndrome | 2025-01-22 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001705948 | SCV001843969 | benign | not provided | 2019-07-16 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001705948 | SCV004130742 | likely benign | not provided | 2024-07-01 | criteria provided, single submitter | clinical testing | KMT2D: BP4, BP7, BS1 |
Breakthrough Genomics, |
RCV001705948 | SCV005213059 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV004758650 | SCV005358644 | likely benign | KMT2D-related disorder | 2024-03-21 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |